Who Pays the Piper?

One of the principle aims of health care research is to understand the pathogenesis of disease and develop therapies that are evaluated objectively. The randomized controlled trial is held as the gold standard in assessing therapeutic benefit. Even with this rigorous approach, however, there are concerns that conflicts of interest may bias interpretation of data. In particular, there is some evidence that trials funded by profit organizations …